Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 76 of 663 for:    SMS

"SMS - Heals My Health"

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03670108
Recruitment Status : Recruiting
First Posted : September 13, 2018
Last Update Posted : September 13, 2018
Sponsor:
Information provided by (Responsible Party):
Serge Perrot, Hôpital Cochin

Brief Summary:
Therapeutic patient education is an approach that has shown its usefulness in rheumatology, but the duration of its impact is limited, and therapeutic revisions are regularly necessary. The practice of physical activity is one of the goals of TPE in rheumatology and new technologies, such as SMS messages represent a possible complementary tool to amplify behavioral changes The study primary objective is to evaluate the impact of individualized SMS compared to standard SMS messages on the physical activity of patients with chronic inflammatory rheumatism or osteoporosis, included in a therapeutic education program. Our hypothesis is that individualized SMS has a higher efficiency compared to standard SMS messages to increase the practice of physical activity in these patients.

Condition or disease
to Help Improve the Quality of Life of Patients

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Impact of Personalized SMS in Relay of Therapeutic Education Programs to Improve the Physical Activity of Patients in Rheumatology
Actual Study Start Date : January 12, 2018
Estimated Primary Completion Date : February 12, 2019
Estimated Study Completion Date : January 12, 2020

Group/Cohort
patients receiving an individualized SMS
patients receiving a standard SMS



Primary Outcome Measures :
  1. physical activity [ Time Frame: 1 YEAR ]
    evaluate the percentage of patients reaching 30 minutes of moderate physical activity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with osteoporosis or inflammatory rheumatism aged between 18 and 75 years, who participated in the patient's therapeutic education program
Criteria

Inclusion Criteria:

  • patient age from 18 to 75 years
  • Participated in therapeutic patient education program osteoporosis disease and inflammatory rheumatism disease
  • Having given their written consent
  • French speaking
  • Possessing a telephone tool that accepts SMS

Exclusion Criteria:

  • Patients unable to read SMS for practical, linguistic or cognitive reasons
  • Patients who can not, for medical reasons or disability, set up 30 minutes of moderate physical activity (walking or other moderate activity) per day
  • Having already participated in a similar study in inflammatory rheumatism or osteoporosis
  • Already having the required level of physical activity: performing more than 30 minutes of moderate physical activity (walking or other moderate activity)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03670108


Contacts
Layout table for location contacts
Contact: Terkia MEDKOUR, PHD 0033158411507 terkia.medkour@aphp.fr

Locations
Layout table for location information
France
Cochin Hospital Recruiting
Paris, France, 75014
Contact: TERKIA MEDKOUR, PHD         
Sponsors and Collaborators
Hôpital Cochin

Layout table for additonal information
Responsible Party: Serge Perrot, professor, Hôpital Cochin
ClinicalTrials.gov Identifier: NCT03670108     History of Changes
Other Study ID Numbers: 2016-A00580-51
First Posted: September 13, 2018    Key Record Dates
Last Update Posted: September 13, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No